ALUR vs. BLUA, KRMD, BWAY, STIM, DCTH, MGRM, PDEX, TELA, NVNO, and ICCM
Should you be buying Allurion Technologies stock or one of its competitors? The main competitors of Allurion Technologies include BlueRiver Acquisition (BLUA), KORU Medical Systems (KRMD), BrainsWay (BWAY), Neuronetics (STIM), Delcath Systems (DCTH), Monogram Orthopaedics (MGRM), Pro-Dex (PDEX), TELA Bio (TELA), enVVeno Medical (NVNO), and IceCure Medical (ICCM). These companies are all part of the "surgical & medical instruments" industry.
Allurion Technologies (NYSE:ALUR) and BlueRiver Acquisition (NYSE:BLUA) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, community ranking, analyst recommendations, earnings, media sentiment, risk, institutional ownership, valuation and profitability.
BlueRiver Acquisition has lower revenue, but higher earnings than Allurion Technologies.
In the previous week, Allurion Technologies had 3 more articles in the media than BlueRiver Acquisition. MarketBeat recorded 5 mentions for Allurion Technologies and 2 mentions for BlueRiver Acquisition. Allurion Technologies' average media sentiment score of 0.39 beat BlueRiver Acquisition's score of 0.00 indicating that Allurion Technologies is being referred to more favorably in the media.
Allurion Technologies received 2 more outperform votes than BlueRiver Acquisition when rated by MarketBeat users.
Allurion Technologies currently has a consensus price target of $5.00, indicating a potential upside of 150.00%. Given Allurion Technologies' higher possible upside, equities research analysts plainly believe Allurion Technologies is more favorable than BlueRiver Acquisition.
21.4% of Allurion Technologies shares are owned by institutional investors. Comparatively, 22.3% of BlueRiver Acquisition shares are owned by institutional investors. 20.0% of Allurion Technologies shares are owned by company insiders. Comparatively, 79.0% of BlueRiver Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Summary
Allurion Technologies beats BlueRiver Acquisition on 6 of the 10 factors compared between the two stocks.
Get Allurion Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for ALUR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ALUR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Allurion Technologies Competitors List
Related Companies and Tools
